NCT05048160 2022-05-09
A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Unknown
Mabwell (Shanghai) Bioscience Co., Ltd.
University of Roma La Sapienza
National Cancer Institute (NCI)
National Cancer Institute (NCI)